| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f1cc134e139490e374ccf80c05d94857 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65616 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6561 |
| filingDate |
2013-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82a6e29c67f9b1c05b2f642af53ce3c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b1c1dd3f60d82675d39293ef2a859cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c438121bde52ddbff75c8dadde057032 |
| publicationDate |
2014-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-103936738-A |
| titleOfInvention |
Xanthine derivatives |
| abstract |
The invention discloses xanthine derivatives and isomers. Through normal mice sugar tolerance influence tests and beagle dog in-vivo DPP-IV activity inhibition tests, the compounds show excellent DPP-IV inhibition activity, and are applicable to prepare medicines for treating diseases correlated to dipeptidyl peptidase IV. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021109970-A1 |
| priorityDate |
2013-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |